Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: a prospective open-label study.
Roberto PirrelloBarbara VerroGiulia GrassoPiero RuscittiAdriana CordovaRoberto GiacomelliFrancesco CicciaGiuliana GugginoPublished in: Arthritis research & therapy (2019)
Our study demonstrates that filler injections of hyaluronic acid and platelet-rich plasma represent an efficient local therapeutic alternative for patients affected by scleroderma. The treatment has significantly improved patients' quality of living.
Keyphrases
- hyaluronic acid
- end stage renal disease
- platelet rich plasma
- newly diagnosed
- ejection fraction
- chronic kidney disease
- open label
- peritoneal dialysis
- prognostic factors
- clinical trial
- randomized controlled trial
- systemic sclerosis
- rheumatoid arthritis
- radiation therapy
- study protocol
- rectal cancer
- phase ii
- double blind